GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA

Objective: to detect new molecular genetic markers and therapeutic targets in retroperitoneal myxoid liposarcoma.Material and Methods. DNA samples isolated from tumor tissue and obtained from formalinfixed paraffin-embedded (FFPE) slides were used. DNA was extracted using the GeneRead DNA FFPE Kit (...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Yu. Volkov, V. M. Safronova, S. N. Nered, L. N. Lyubchenko, I. S. Stilidi
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2020-07-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/1491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849253184644579328
author A. Yu. Volkov
V. M. Safronova
S. N. Nered
L. N. Lyubchenko
I. S. Stilidi
author_facet A. Yu. Volkov
V. M. Safronova
S. N. Nered
L. N. Lyubchenko
I. S. Stilidi
author_sort A. Yu. Volkov
collection DOAJ
description Objective: to detect new molecular genetic markers and therapeutic targets in retroperitoneal myxoid liposarcoma.Material and Methods. DNA samples isolated from tumor tissue and obtained from formalinfixed paraffin-embedded (FFPE) slides were used. DNA was extracted using the GeneRead DNA FFPE Kit (50) (Qiagen). High-throughput next generation sequencing (NGS) using the GeneReader Actionable Insights Tumor Panel (GRTP – 101X) on the QCI Analyzer version 1.1 platform (Qiagen) was used for molecular genetic analysis of 12 genes involved in carcinogenesis: KRAS, NRAS, KIT, BRAF, PDGFRA, ALK, EGFR, ERBB2, PIK3CA, ERBB3, ESR1, RAF1.Results. Targeted sequencing of retroperitoneal extra-organ myxoid liposarcoma demonstrated genetic heterogeneity. Our study was the first to describe mutations and polymorphic variants in genes, such as EGFR, PIK3CA, ALK, BRAF, ERBB2 / 3, ESR1, KIT, PDGFRA in myxoid liposarcoma.Conclusion. This study demonstrated a wide range of molecular genetic rearrangements in retroperitoneal extra-organ myxoid liposarcoma. Synonymous mutations in the EGFR (Q787Q) and PDGFRA (P567P) genes were detected in all cases (100 %). Missense mutations in the ERBB2 gene (P1170A) and synonymous mutations in the ALK (G845G) and BRAF genes were identified in 75 % of cases. Missense mutation in the PIK3CA gene (I391M) was detected in 25 % of cases. The gene polymorphisms presented in this paper are most likely involved in the carcinogenesis of retroperitoneal myxoid liposarcoma. Further studies with larger patient groups and multivariate analysis of long-term treatment results are required.
format Article
id doaj-art-abeb9da4493a40418b0e2c0df1a43701
institution Kabale University
issn 1814-4861
2312-3168
language Russian
publishDate 2020-07-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-abeb9da4493a40418b0e2c0df1a437012025-08-20T03:56:24ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682020-07-01193899610.21294/1814-4861-2020-19-3-89-96750GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMAA. Yu. Volkov0V. M. Safronova1S. N. Nered2L. N. Lyubchenko3I. S. Stilidi4N.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of RussiaN.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of RussiaN.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of RussiaN.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of Russia; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)N.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of RussiaObjective: to detect new molecular genetic markers and therapeutic targets in retroperitoneal myxoid liposarcoma.Material and Methods. DNA samples isolated from tumor tissue and obtained from formalinfixed paraffin-embedded (FFPE) slides were used. DNA was extracted using the GeneRead DNA FFPE Kit (50) (Qiagen). High-throughput next generation sequencing (NGS) using the GeneReader Actionable Insights Tumor Panel (GRTP – 101X) on the QCI Analyzer version 1.1 platform (Qiagen) was used for molecular genetic analysis of 12 genes involved in carcinogenesis: KRAS, NRAS, KIT, BRAF, PDGFRA, ALK, EGFR, ERBB2, PIK3CA, ERBB3, ESR1, RAF1.Results. Targeted sequencing of retroperitoneal extra-organ myxoid liposarcoma demonstrated genetic heterogeneity. Our study was the first to describe mutations and polymorphic variants in genes, such as EGFR, PIK3CA, ALK, BRAF, ERBB2 / 3, ESR1, KIT, PDGFRA in myxoid liposarcoma.Conclusion. This study demonstrated a wide range of molecular genetic rearrangements in retroperitoneal extra-organ myxoid liposarcoma. Synonymous mutations in the EGFR (Q787Q) and PDGFRA (P567P) genes were detected in all cases (100 %). Missense mutations in the ERBB2 gene (P1170A) and synonymous mutations in the ALK (G845G) and BRAF genes were identified in 75 % of cases. Missense mutation in the PIK3CA gene (I391M) was detected in 25 % of cases. The gene polymorphisms presented in this paper are most likely involved in the carcinogenesis of retroperitoneal myxoid liposarcoma. Further studies with larger patient groups and multivariate analysis of long-term treatment results are required.https://www.siboncoj.ru/jour/article/view/1491liposarcomamyxoid liposarcomaextra-organ retroperitoneal tumornext-generation sequencing (ngs)polymorphismmutationegfrpdgfraerbb2braf
spellingShingle A. Yu. Volkov
V. M. Safronova
S. N. Nered
L. N. Lyubchenko
I. S. Stilidi
GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
Сибирский онкологический журнал
liposarcoma
myxoid liposarcoma
extra-organ retroperitoneal tumor
next-generation sequencing (ngs)
polymorphism
mutation
egfr
pdgfra
erbb2
braf
title GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
title_full GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
title_fullStr GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
title_full_unstemmed GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
title_short GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
title_sort genetic polymorphism of retroperitoneal myxoid liposarcoma
topic liposarcoma
myxoid liposarcoma
extra-organ retroperitoneal tumor
next-generation sequencing (ngs)
polymorphism
mutation
egfr
pdgfra
erbb2
braf
url https://www.siboncoj.ru/jour/article/view/1491
work_keys_str_mv AT ayuvolkov geneticpolymorphismofretroperitonealmyxoidliposarcoma
AT vmsafronova geneticpolymorphismofretroperitonealmyxoidliposarcoma
AT snnered geneticpolymorphismofretroperitonealmyxoidliposarcoma
AT lnlyubchenko geneticpolymorphismofretroperitonealmyxoidliposarcoma
AT isstilidi geneticpolymorphismofretroperitonealmyxoidliposarcoma